share_log

HC Wainwright & Co. Reiterates Buy on Candel Therapeutics, Maintains $11 Price Target

HC Wainwright & Co. Reiterates Buy on Candel Therapeutics, Maintains $11 Price Target

HC韦恩赖特证券继续买入Candel Therapeutics,维持11美元的目标价
Benzinga ·  11/18 07:50

HC Wainwright & Co. analyst Vernon Bernardino reiterates Candel Therapeutics (NASDAQ:CADL) with a Buy and maintains $11 price target.

HC韦恩赖特证券分析师Vernon Bernardino重申对Candel Therapeutics(纳斯达克:CADL)的买入评级,并保持11美元的目标价

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发